Zetia: Targeted Cholesterol Management for Better Cardiovascular Health
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.46 | $43.86 (0%) | 🛒 Add to cart |
| 60 | $1.18 | $87.72 $70.52 (20%) | 🛒 Add to cart |
| 90 | $1.08 | $131.58 $97.18 (26%) | 🛒 Add to cart |
| 120 | $1.04 | $175.44 $124.70 (29%) | 🛒 Add to cart |
| 180 | $0.99 | $263.16 $178.02 (32%) | 🛒 Add to cart |
| 270 | $0.96 | $394.74 $258.86 (34%) | 🛒 Add to cart |
| 360 | $0.94
Best per pill | $526.32 $338.84 (36%) | 🛒 Add to cart |
Synonyms | |||
Zetia (ezetimibe) is a prescription medication specifically designed to lower elevated levels of LDL cholesterol, commonly known as “bad” cholesterol. It operates through a unique mechanism of action by inhibiting the absorption of cholesterol in the small intestine, complementing other lipid-lowering strategies. This medication is often utilized when dietary changes and other cholesterol treatments alone are insufficient, or in combination with statins for enhanced efficacy. Zetia represents a focused therapeutic option for patients requiring additional support in achieving their lipid goals, contributing to a comprehensive approach to cardiovascular risk reduction.
Features
- Active ingredient: ezetimibe 10 mg
- Available in oral tablet form
- Functions by selectively inhibiting intestinal cholesterol absorption
- Does not inhibit cholesterol synthesis in the liver or increase bile acid excretion
- Can be administered with or without food
- Compatible with most other cholesterol-lowering medications
Benefits
- Effectively reduces LDL cholesterol levels by targeting intestinal absorption
- Provides an alternative mechanism of action for patients intolerant to statin therapy
- Can be combined with statins for additive cholesterol-lowering effects
- Helps improve overall lipid profiles when used as part of comprehensive management
- Supports cardiovascular risk reduction strategies
- Offers once-daily dosing convenience for improved adherence
Common use
Zetia is primarily indicated as adjunctive therapy to diet for the reduction of elevated total cholesterol, LDL cholesterol, and apolipoprotein B in patients with primary hyperlipidemia, either alone or in combination with an HMG-CoA reductase inhibitor (statin). It is also used in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatments. Additionally, Zetia may be prescribed for patients with homozygous sitosterolemia to reduce elevated plant sterol levels.
Dosage and direction
The recommended dosage of Zetia is 10 mg once daily, with or without food. It can be taken at any time of day, though consistency in timing is recommended for optimal adherence. When used in combination with a statin, Zetia may be administered simultaneously with the statin or at separate times. For patients with moderate or severe hepatic impairment, dosage adjustment is not necessary, but close monitoring is advised. No dosage adjustment is required for elderly patients or those with renal impairment.
Precautions
Patients should be advised that Zetia is not a substitute for a cholesterol-lowering diet. Regular monitoring of liver function tests is recommended, particularly when used in combination with statins. Patients should report any unexplained muscle pain, tenderness, or weakness to their healthcare provider promptly. Zetia should be used with caution in patients taking cyclosporine due to increased ezetimibe concentrations. Women of childbearing potential should use adequate contraception while taking Zetia.
Contraindications
Zetia is contraindicated in patients with known hypersensitivity to any component of the medication. It should not be used in patients with active liver disease or unexplained persistent elevations in hepatic transaminase levels. Concomitant use with statins is contraindicated in patients with active liver disease or unexplained persistent elevations of serum transaminases. The combination of Zetia with a statin is contraindicated in pregnant and breastfeeding women.
Possible side effects
The most common adverse reactions include upper respiratory tract infection, diarrhea, arthralgia, sinusitis, and pain in extremities. Less frequently reported side effects include fatigue, viral infection, back pain, and influenza. When used in combination with statins, additional side effects may include increased transaminases, myalgia, and elevated creatine phosphokinase. Rare cases of hypersensitivity reactions, including rash, urticaria, and angioedema, have been reported.
Drug interaction
Zetia may increase cyclosporine levels; cyclosporine concentrations should be monitored in patients taking both medications. Concomitant administration with cholestyramine decreases the absorption of ezetimibe. Fibric acid derivatives may increase the risk of cholelithiasis when combined with Zetia. While no significant interactions have been observed with warfarin, digoxin, glipizide, or oral contraceptives, careful monitoring is still recommended when initiating combination therapy.
Missed dose
If a dose is missed, patients should take it as soon as they remember, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should not take double doses to make up for a missed dose. Consistency in daily administration is important for maintaining stable cholesterol-lowering effects.
Overdose
In the event of overdose, supportive and symptomatic treatment should be provided. There is no specific antidote for ezetimibe overdose. Clinical experience with doses higher than the recommended therapeutic dose is limited. Hemodialysis is not expected to significantly enhance elimination of ezetimibe due to its extensive protein binding. Patients should be monitored for potential adverse effects and treated appropriately.
Storage
Zetia tablets should be stored at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Keep the medication in its original container with the lid tightly closed. Protect from light and moisture. Store out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Zetia is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Patients should not initiate, discontinue, or change dosage without consulting their physician. Individual results may vary, and the benefits and risks of treatment should be carefully considered for each patient.
Reviews
Clinical studies have demonstrated that Zetia significantly reduces LDL cholesterol levels by approximately 18-20% when used as monotherapy and provides additional 25% reduction when added to ongoing statin therapy. Many healthcare providers appreciate its unique mechanism of action and favorable safety profile. Patients often report good tolerance and convenience of once-daily dosing. However, some experts emphasize that outcome studies showing cardiovascular risk reduction are more robust for statins, and Zetia is typically reserved for specific clinical situations where additional LDL lowering is needed beyond what can be achieved with statins alone.